In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case study

Tanmayee Basu, Atul Kumar Upadhyay

Open source

DOI: 10.1007/s40203-025-00447-w
Published: 2025-10-27
Container: In Silico Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40203-025-00447-w,
  title = {In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case study},
  author = {Tanmayee Basu and Atul Kumar Upadhyay},
  year = {2025},
  journal = {In Silico Pharmacology},
  doi = {10.1007/s40203-025-00447-w},
  url = {https://doi.org/10.1007/s40203-025-00447-w}
}

RIS

TY  - JOUR
TI  - In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case study
AU  - Tanmayee Basu
AU  - Atul Kumar Upadhyay
PY  - 2025
JO  - In Silico Pharmacology
DO  - 10.1007/s40203-025-00447-w
UR  - https://doi.org/10.1007/s40203-025-00447-w
ER  -

APA

Basu, T., & Upadhyay, A. K. (2025). In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case study. In Silico Pharmacology. https://doi.org/10.1007/s40203-025-00447-w

Source records

crossref · retrieved 2026-09-26T20:07:23.357Z